Literature DB >> 12504046

Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design.

George Hruby1, Michael Barton, Sharon Miles, Susan Carroll, Elias Nasser, Graham Stevens.   

Abstract

PURPOSE: To examine the sites of pelvic recurrence in patients with rectal cancer previously untreated with radiotherapy to determine the relative frequency and location of recurrence within the pelvis. METHODS AND MATERIALS: The records of patients with locally recurrent rectal cancer referred to three radiation oncology departments between 1984 and 1997 were reviewed. The data collected included the date and type of the initial resection and the pathologic findings. The site of recurrence within the pelvis, presence of metastasis, and date of recurrence were documented.
RESULTS: A total of 269 patients were included. Tumor had invaded through the muscularis in 74% and involved other organs in 9%. Fifty-two percent of patients were node positive at initial surgery. The median time to local recurrence from surgery was 18 months (range 15-20) and from local recurrence to death was 14 months (range 12-17). Both the initial tumor stage and the resection type influenced the recurrence location within the pelvis (p <0.01). T4 tumors comprised only 9% of initial T stage tumors but accounted for 38% of anterior central pelvic recurrences (p <0.01). All perineal recurrences occurred after abdominoperineal resection. The sites of recurrence within the pelvis were the posterior central pelvis (47%) and anastomotic (21%).
CONCLUSION: If those patients with T4 tumors at presentation were excluded, 89% had local recurrence at, or posterior to, the anastomosis. Furthermore, if we exclude both patients who underwent abdominoperineal resection and those with T4 tumors at presentation, the rate increases to 93%. The rate of recurrence anteriorly (7%) does not justify routine radiation of the anterior pelvis beyond that required to adequately cover the anastomotic site.

Entities:  

Mesh:

Year:  2003        PMID: 12504046     DOI: 10.1016/s0360-3016(02)03812-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  [Locally recurrent rectal carcinoma].

Authors:  Th Lehnert; M Golling; J Buchholz
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  [Improvements in detection of rectal cancer recurrence by multiplanar reconstruction].

Authors:  C A Stückle; K F Haegele; M Jendreck; R Kickuth; O Schneider; G Hohlbach; D Liermann
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

Review 3.  Patterns of local recurrence in rectal cancer after a multidisciplinary approach.

Authors:  Jose M Enríquez-Navascués; Nerea Borda; Aintzane Lizerazu; Carlos Placer; Jose L Elosegui; Juan P Ciria; Adelaida Lacasta; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 4.  Locally Recurrent Rectal Cancer According to a Standardized MRI Classification System: A Systematic Review of the Literature.

Authors:  Zena Rokan; Constantinos Simillis; Christos Kontovounisios; Brendan Moran; Paris Tekkis; Gina Brown
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

Review 5.  [Therapy of locally recurrent rectal carcinoma].

Authors:  H G Hempen; H R Raab
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 6.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

7.  Pelvic sidewall involvement in recurrent rectal cancer.

Authors:  Stefan Höcht; Benno Mann; Christoph-Thomas Germer; Riad Hammad; Alessandra Siegmann; Thomas Wiegel; Heinz-Johannes Buhr; Wolfgang Hinkelbein
Journal:  Int J Colorectal Dis       Date:  2003-10-03       Impact factor: 2.571

8.  Systematic review of classification systems for locally recurrent rectal cancer.

Authors:  Z Rokan; C Simillis; C Kontovounisios; B J Moran; P Tekkis; G Brown
Journal:  BJS Open       Date:  2021-05-07

9.  Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

Authors:  Raphaëla C Dresen; Marleen J Gosens; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Adriaan J van den Brule; Hetty A van den Berg; Harm J Rutten
Journal:  Ann Surg Oncol       Date:  2008-04-04       Impact factor: 5.344

10.  Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.

Authors:  G Klautke; U Küchenmeister; T Foitzik; K Ludwig; F Prall; E Klar; R Fietkau
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.